TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GMAB

Genmab AS

Healthcare · Biotechnology

35.30$ +1.4% vs. previous close Closing price · As of: Sep 25, 2026

Investor relations

Report Dates

Investor relations overview for Genmab AS (GMAB): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 48.4 % 23 Q4 23 · -53.3 % 23 Q1 24 · 107.1 % 24 Q2 24 · 0.0 % 24 Q3 24 · -12.1 % 24 Q4 24 · 200.0 % 24 Q1 25 · 34.8 % 25 Q2 25 · 38.5 % 25 Q3 25 · 44.4 % 25 Q4 25 · -43.2 % 25 Q1 26 · -31.6 % 26 Q2 26 · 46.0 % 26

EPS estimate beaten

Full history 16 of 29 quarters (55%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

  • 08/06/2026 Earnings Call Q2 2026 Open →
  • 05/14/2026 Earnings Call Q1 2026 Open →
  • 02/17/2026 Earnings Call Q4 2025 Open →
  • 11/08/2025 Earnings Call Q3 2025 Open →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?